Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer
  1. Home
  2. Publications
  3. Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer

Supplementary Data from Targeted MDM2 Degradation Reveals a New Vulnerability for p53-Inactivated Triple-Negative Breast Cancer

Authors:
  • CAClare M. Adams
    Clare M. Adams
  • RMRamkrishna Mitra
    Ramkrishna Mitra
  • YXYoucai Xiao
    Youcai Xiao
  • PMPeter Michener
    Peter Michener
  • JPJuan Palazzo
    Juan Palazzo
  • ACAllen Chao
    Allen Chao
  • JGJitendra Gour
    Jitendra Gour
  • JCJoel Cassel
    Joel Cassel
  • JSJoseph M. Salvino
    Joseph M. Salvino
  • CEChristine M. Eischen
    Christine M. Eischen

Open Access
Publisher website
Google Scholar
  • 11 December 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2159-8290.30859506
Abstract
Supplementary Materials and Methods, Tables S1-S3, Figures S1-S7
Keywords
  • BREAST CANCER
  • CELL DEATH AND SENESCENCE
  • TRANSCRIPTIONAL CONTROL OF APOPTOSIS
  • DRUG TARGETS
  • ONCOPROTEIN & TUMOR SUPPRESSOR DRUG TARGETS
  • ONCOGENES & TUMOR SUPPRESSORS
  • TP53
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.